Connect with us
Prague Gaming & TECH Summit 2024

Artificial Intelligence

Global Radiation Therapy Equipment Market to Reach US$7.8 Billion by the Year 2027

Published

on

New York, May 10, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Radiation Therapy Equipment Industry” – https://www.reportlinker.com/p05442588/?utm_source=GNW
– Online interactive peer-to-peer collaborative bespoke updates
– Access to our digital archives and MarketGlass Research Platform
– Complimentary updates for one yearGlobal Radiation Therapy Equipment Market to Reach US$7.8 Billion by the Year 2027

– Amid the COVID-19 crisis, the global market for Radiation Therapy Equipment estimated at US$5.2 Billion in the year 2020, is projected to reach a revised size of US$7.8 Billion by 2027, growing at a CAGR of 5.9% over the analysis period 2020-2027.External Beam Radiation Therapy, one of the segments analyzed in the report, is projected to grow at a 6.1% CAGR to reach US$6.6 Billion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Internal Radiation Therapy segment is readjusted to a revised 4.8% CAGR for the next 7-year period. This segment currently accounts for a 9.9% share of the global Radiation Therapy Equipment market.

– The U.S. Accounts for Over 36.9% of Global Market Size in 2020, While China is Forecast to Grow at a 7.9% CAGR for the Period of 2020-2027

– The Radiation Therapy Equipment market in the U.S. is estimated at US$1.9 Billion in the year 2020. The country currently accounts for a 36.87% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$678 Million in the year 2027 trailing a CAGR of 7.9% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.4% and 4.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.7% CAGR while Rest of European market (as defined in the study) will reach US$678 Million by the year 2027.

– Systemic Radiation Therapy Segment Corners a 6.5% Share in 2020

– In the global Systemic Radiation Therapy segment, USA, Canada, Japan, China and Europe will drive the 4.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$288 Million in the year 2020 will reach a projected size of US$382.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1 Billion by the year 2027, while Latin America will expand at a 5.2% CAGR through the analysis period.

– Select Competitors (Total 57 Featured) Accuray Incorporated BrainLab AG Elekta AB GE Healthcare Hitachi America, Ltd. Hitachi, Ltd. IBA Group Nordion (Canada) Inc. Philips Healthcare RaySearch Laboratories AB Sumitomo Heavy Industries Ltd. Varian Medical Systems, Inc.

Read the full report: https://www.reportlinker.com/p05442588/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Radiation Therapy: An Effective, Affordable, Non-Surgical
Treatment Option for Cancer Patients
Radiation Therapy Equipment: Enabling Best-in-Class Cancer Care
Impact of COVID-19 and a Looming Global Recession
2020 Marked as a Year of Disruption & Transformation
As the Race between the Virus & Vaccines Intensifies, Where is
the World Economy Headed?
EXHIBIT 1: World Economic Growth Projections (Real GDP, Annual
% Change) for 2020 through 2022
Pandemic Impacts Radiation Oncology Services
Amidst the COVID-19 Pandemic, Radiation Oncology Centers
Implement Workflow Changes
Potential Role for Radiation Therapy in Treatment of COVID-19
AI, Machine Learning & Other IT Technologies to Tackle
Pandemic-Led Cancer Backlogs
Potential Role of Low-Dose Radiation Therapy for COVID-19
Treatment
Low-Dose and Ultra-Low Dose Radiotherapy: Treatment Modality
for COVID-19-Related Pneumonia?
Competitive Landscape
EXHIBIT 2: Radiation Therapy Equipment – Global Key Competitors
Percentage Market Share in 2022 (E)
Competitive Market Presence – Strong/Active/Niche/Trivial for
54 Players Worldwide in 2022 (E)
LINACs Market: Dominated by Variant and Elekta
EXHIBIT 3: Global Linear Accelerators (LINACs) Market:
Percentage Breakdown of Installed Base by Leading Players for
2019
EXHIBIT 4: Global Linear Accelerators (LINACs) Market:
Percentage Breakdown of New Orders by Leading Players for 2019
IBA: The Predominant Player in Proton Therapy Equipment Market
EXHIBIT 5: Global Proton Therapy Market Breakdown by Number of
PT Rooms (in %) by Leading Players: 2020
Treatment Planning Systems Market
EXHIBIT 6: Global Treatment Planning Systems Market Share
Breakdown of Sales (in %) by Leading Players for 2020
Global Market Prospects & Outlook
EXHIBIT 7: Utilization Rate (%) of Radiation Therapy by Type of
Cancer
Developed Regions Dominate Radiotherapy Equipment Market
Replacement Demand Drives Revenue Growth in Developed Regions
Developing Regions to Spearhead Future Growth
World Brands
Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Rising Incidence of Cancer & Need to Reduce Cancer-Related
Mortality: Cornerstone for Present & Future Growth
EXHIBIT 8: Global Cancer Incidence: Number of New Cancer Cases
in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
EXHIBIT 9: Global Number of New Cancer Cases and Cancer-related
Deaths by Cancer Site for 2020
EXHIBIT 10: Number of New Cancer Cases and Deaths (in Million)
by Region for 2020
Underserved Demand for Radiation Oncology Therapy Drives Market
EXHIBIT 11: Projected Need for Radiation Oncology Centers,
Radiation Oncologists, Medical Physicists and Radiation
Technologists by the Year 2035
EXHIBIT 12: Percentage of Cancer Patients Treated with
Radiotherapy in Select Countries
Increasing Healthcare Expenditure Creates Conducive Environment
EXHIBIT 13: World Healthcare Expenditure (In US$ Trillion) for
the Years for 2017, 2019, 2021, and 2023
External Beam Radiotherapy Equipment: The Largest Product Category
Linear Accelerator (LINAC): A Vital Constituent of EBRT
LINACs Replace Conventional Radiotherapy Equipment
MRI-LINACs Revolutionizes Cancer Care
EXHIBIT 14: Penetration of LINACs Worldwide: Number of LINACs
Per Million Population in Select Countries
Proton Therapy Revolutionizes Radiation Therapy Space
EXHIBIT 15: Global Proton Therapy Market by Region/Country
(in %) for 2022E
Intensely-Modulated Proton Therapy (IMPT): The Future of Proton
Therapy
High Cost: A Barrier to Adoption
Systemic Radiation Therapy Equipment: A Small Yet Growing Market
Internal Radiation Therapy Equipment: Overview
Intensity Modulated Radiation Therapy (IMRT) Equipment Help
Hospitals Improve Outcomes
Stereotactic Radio Surgery Treatment Gaining Traction
Adaptive Radiation Therapy (ART) Gains Significance
Imaging Technology Plays Central Role in Radiation Therapy
Image Guided Radiotherapy (IGRT) Grows in Prominence
Surface Guided Radiation Therapy Systems Market: Stable Growth
Outlook
Oncology Information Systems (OIS): Assisting Management of
Complex and Advanced Radiation Therapies
Data-Intensive Radiation Oncology Promotes OIS Connection to EHRs
Advancing Radiation Therapy Raises Importance of Treatment
Planning Systems
Progressive Advancements Augment Use Case of Treatment Planning
Platforms
Increasing Role of Imaging in Treatment Planning
Radiotherapy Positioning Devices Market: Poised for Growth
Innovative Therapies & Notable Trends Revolutionize Radiation
Therapy Market
Flash Radiation Therapy: Future Trend
Image-guided Radiotherapy Systems
Proton Therapy Becomes a Cancer Mainstream Treatment Option
PSMA PET: Enhancing the Care for Prostate Cancer
Synthetic CT from MRI Holds Significant Promise
Intraoperative Radiation Therapy Market
Hypofractionation and Advanced Imaging Integration to Deliver
Greater Radiation Therapy Outcomes
Technological Innovations Spur Radiation Therapy Equipment Market
Hybrid Systems Enable Superior Treatment Efficacy
Computer Simulators Improve Radiation Therapy Outcomes
Need to Boost Productivity Accelerates Deployment of High-Tech
Equipment
Personalized Radiation Therapy: The Way Forward
Promising Role of Brachytherapy Device and Intensity-Modulated
Radiation for Eye Cancer Treatment
Digital Solution Enhances RT Planning Process Efficiency
Deep Learning Technology
Select Innovations in Radiation Therapy Space
Theragnostics – An Emerging Treatment Modality Backed by Imaging
Artificial Intelligence and Machine Learning in Radiotherapy
Treatment
Select Uses of AI in Radiation Therapy Devices
Integration of AI and Rising Speed of Treatment Planning Systems
Technology-driven Research for Development in Radiotherapy
Refurbished Radiation Therapy Equipment: Changing with the Times
WHO/IAEA Presents Guidance on Radiation Therapy Equipment
Emphasis on Radiotherapy-based Management during COVID-19 Pandemic
Technical Issues Challenge Delivery of Quality of RT During
COVID-19 Unlock
Expanding Aging Population at High Risk of Cancer to Benefit
Market Expansion
EXHIBIT 16: Global Aging Population Statistics for the 65+ Age
Group in Million by Geographic Region for the Years 2019,
2025, 2035 and 2050
EXHIBIT 17: Elderly Population (65+ Years) as a % of Total
Population by Developed, Less Developed and Least Developed
Regions: 2019 & 2030
Challenges Confronting Radiation Therapy Equipment Market
Radiation Therapy: Product Overview
Types of Radiation Therapy
External Beam Radiation Therapy (EBRT/XRT) or Teletherapy
Internal Beam Radio Therapy/Brachytherapy
Systemic Radioisotope Therapy (RIT)
Other Forms of Radiation Therapy
Linear Accelerators (LINACs)
Radiation Therapy Simulator
Treatment Planning System: An Innovative Technique in Radiation
Therapy
Radiotherapy Accessories
Tumor Localization and Treatment Simulation Devices
Patient Restraint and Repositioning Devices
Field-Shaping Devices
Dose-Modifying Devices

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Radiation Therapy Equipment by Geographic Region – USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Radiation Therapy Equipment
by Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Radiation Therapy
Equipment by Geographic Region – Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa Markets for Years 2012,
2021 & 2027

Table 4: World Recent Past, Current & Future Analysis for
External Beam Radiation Therapy by Geographic Region – USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for External Beam Radiation
Therapy by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for External Beam Radiation
Therapy by Geographic Region – Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027

Table 7: World Recent Past, Current & Future Analysis for
Internal Radiation Therapy by Geographic Region – USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 8: World Historic Review for Internal Radiation Therapy
by Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Internal Radiation
Therapy by Geographic Region – Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027

Table 10: World Recent Past, Current & Future Analysis for
Systemic Radiation Therapy by Geographic Region – USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Systemic Radiation Therapy
by Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Systemic Radiation
Therapy by Geographic Region – Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027

Table 13: World Recent Past, Current & Future Analysis for
Hospitals by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Hospitals by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 15: World 15-Year Perspective for Hospitals by Geographic
Region – Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027

Table 16: World Recent Past, Current & Future Analysis for
Other End-Uses by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets – Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Other End-Uses by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Other End-Uses by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

III. MARKET ANALYSIS

UNITED STATES
Radiation Therapy Equipment Market Presence – Strong/Active/
Niche/Trivial – Key Competitors in the United States for 2022
(E)
United States: The Prime Market for Radiation Therapy Equipment
Radiation Therapy in the US: An Overview
Rising Incidence of Cancer & Shift towards Non-Invasive
Procedures Widens Market Prospects
EXHIBIT 18: Estimated Number of New Cancer Cases in the US by
Gender and Affected Site for 2022
EXHIBIT 19: Estimated Number of Cancer-Related Deaths in the US
by Gender and Body Site for 2022
EXHIBIT 20: Estimated Number of New Cancer Cases in the US by
State for 2022
EXHIBIT 21: Estimated Number of Cancer-Related Deaths in the US
by State for 2022
Rising Spending on Cancer Care
EXHIBIT 22: Cost of Cancer Care in the US: Lifetime Healthcare
Spending (in $) by Cancer Type
EXHIBIT 23: National Spending on Cancer Care by Cancer Site
(in US$ Billion) for 2015 and 2020
Replacements Drive Unit Installations
Innovations Propel Market Growth
External Radiation Therapy: The Most Common Type of RT
Treatment for Cancer
Proton Therapy Gaining Traction in Cancer Care
IMRT: Enabling Precise Treatments for Specific Cancers
Systemic Radiotherapy Market: High Therapy Costs Limit Growth
Opportunities
Treatment Planning Software Holds Prominence
Reimbursement Rates for Cancer Treatment with Radiation
Indicate Notable Disparity among States
Oncology Care Model to Improve Quality and Reduce Financial
Toxicity of Cancer Care
Competition
EXHIBIT 24: US Radiotherapy Equipment Market Breakdown by
Leading Players: 2022E
EXHIBIT 25: US Proton Therapy Equipment Market Share Breakdown
of Installed Base by Company: 2022E
Market Analytics
Table 19: USA Recent Past, Current & Future Analysis for
Radiation Therapy Equipment by Type – External Beam Radiation
Therapy, Internal Radiation Therapy and Systemic Radiation
Therapy – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 20: USA Historic Review for Radiation Therapy Equipment
by Type – External Beam Radiation Therapy, Internal Radiation
Therapy and Systemic Radiation Therapy Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 21: USA 15-Year Perspective for Radiation Therapy
Equipment by Type – Percentage Breakdown of Value Sales for
External Beam Radiation Therapy, Internal Radiation Therapy and
Systemic Radiation Therapy for the Years 2012, 2021 & 2027

Table 22: USA Recent Past, Current & Future Analysis for
Radiation Therapy Equipment by End-Use – Hospitals and Other
End-Uses – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 23: USA Historic Review for Radiation Therapy Equipment
by End-Use – Hospitals and Other End-Uses Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 24: USA 15-Year Perspective for Radiation Therapy
Equipment by End-Use – Percentage Breakdown of Value Sales for
Hospitals and Other End-Uses for the Years 2012, 2021 & 2027

CANADA
Market Overview
EXHIBIT 26: Number of New Cancer Cases by Cancer Type in
Canada: 2020
Market Analytics
Table 25: Canada Recent Past, Current & Future Analysis for
Radiation Therapy Equipment by Type – External Beam Radiation
Therapy, Internal Radiation Therapy and Systemic Radiation
Therapy – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 26: Canada Historic Review for Radiation Therapy
Equipment by Type – External Beam Radiation Therapy, Internal
Radiation Therapy and Systemic Radiation Therapy Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 27: Canada 15-Year Perspective for Radiation Therapy
Equipment by Type – Percentage Breakdown of Value Sales for
External Beam Radiation Therapy, Internal Radiation Therapy and
Systemic Radiation Therapy for the Years 2012, 2021 & 2027

Table 28: Canada Recent Past, Current & Future Analysis for
Radiation Therapy Equipment by End-Use – Hospitals and Other
End-Uses – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 29: Canada Historic Review for Radiation Therapy
Equipment by End-Use – Hospitals and Other End-Uses Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 30: Canada 15-Year Perspective for Radiation Therapy
Equipment by End-Use – Percentage Breakdown of Value Sales for
Hospitals and Other End-Uses for the Years 2012, 2021 & 2027

JAPAN
Radiation Therapy Equipment Market Presence – Strong/Active/
Niche/Trivial – Key Competitors in Japan for 2022 (E)
Market Overview
EXHIBIT 27: Cancer Related Incidence and Deaths in Japan: 2020
Competition
EXHIBIT 28: Japanese LINACs Market Breakdown by Competitor
(in %) for 2022E
EXHIBIT 29: Japanese Proton Therapy Equipment Market Share
Breakdown of Leading Players: 2022E
Market Analytics
Table 31: Japan Recent Past, Current & Future Analysis for
Radiation Therapy Equipment by Type – External Beam Radiation
Therapy, Internal Radiation Therapy and Systemic Radiation
Therapy – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 32: Japan Historic Review for Radiation Therapy Equipment
by Type – External Beam Radiation Therapy, Internal Radiation
Therapy and Systemic Radiation Therapy Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 33: Japan 15-Year Perspective for Radiation Therapy
Equipment by Type – Percentage Breakdown of Value Sales for
External Beam Radiation Therapy, Internal Radiation Therapy and
Systemic Radiation Therapy for the Years 2012, 2021 & 2027

Table 34: Japan Recent Past, Current & Future Analysis for
Radiation Therapy Equipment by End-Use – Hospitals and Other
End-Uses – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 35: Japan Historic Review for Radiation Therapy Equipment
by End-Use – Hospitals and Other End-Uses Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 36: Japan 15-Year Perspective for Radiation Therapy
Equipment by End-Use – Percentage Breakdown of Value Sales for
Hospitals and Other End-Uses for the Years 2012, 2021 & 2027

CHINA
Market Overview
EXHIBIT 30: Number of New Cancer Cases for Both Sexes by Cancer
Type for 2020
Competition
EXHIBIT 31: Chinese Radiation Therapy Equipment Market
Breakdown by Leading Companies: 2022E
Market Analytics
Table 37: China Recent Past, Current & Future Analysis for
Radiation Therapy Equipment by Type – External Beam Radiation
Therapy, Internal Radiation Therapy and Systemic Radiation
Therapy – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 38: China Historic Review for Radiation Therapy Equipment
by Type – External Beam Radiation Therapy, Internal Radiation
Therapy and Systemic Radiation Therapy Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 39: China 15-Year Perspective for Radiation Therapy
Equipment by Type – Percentage Breakdown of Value Sales for
External Beam Radiation Therapy, Internal Radiation Therapy and
Systemic Radiation Therapy for the Years 2012, 2021 & 2027

Table 40: China Recent Past, Current & Future Analysis for
Radiation Therapy Equipment by End-Use – Hospitals and Other
End-Uses – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 41: China Historic Review for Radiation Therapy Equipment
by End-Use – Hospitals and Other End-Uses Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 42: China 15-Year Perspective for Radiation Therapy
Equipment by End-Use – Percentage Breakdown of Value Sales for
Hospitals and Other End-Uses for the Years 2012, 2021 & 2027

EUROPE
Radiation Therapy Equipment Market Presence – Strong/Active/
Niche/Trivial – Key Competitors in Europe for 2022 (E)
Rising Cancer Incidence Sustains Growth in Radiation Therapy
Equipment Market
EXHIBIT 32: Number of New Cancer Cases in Europe: 2012, 2018,
and 2025
EXHIBIT 33: Number of Radiotherapy Centers by Type in Select
European Countries
Competition
EXHIBIT 34: EMEA Radiation Therapy Equipment Market by Leading
Players for 2022E
EXHIBIT 35: European Proton Therapy Equipment Market Share
Breakdown (in %) by Competitors: 2022E
Market Analytics
Table 43: Europe Recent Past, Current & Future Analysis for
Radiation Therapy Equipment by Geographic Region – France,
Germany, Italy, UK, Spain, Russia and Rest of Europe Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 44: Europe Historic Review for Radiation Therapy
Equipment by Geographic Region – France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 45: Europe 15-Year Perspective for Radiation Therapy
Equipment by Geographic Region – Percentage Breakdown of Value
Sales for France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets for Years 2012, 2021 & 2027

Table 46: Europe Recent Past, Current & Future Analysis for
Radiation Therapy Equipment by Type – External Beam Radiation
Therapy, Internal Radiation Therapy and Systemic Radiation
Therapy – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 47: Europe Historic Review for Radiation Therapy
Equipment by Type – External Beam Radiation Therapy, Internal
Radiation Therapy and Systemic Radiation Therapy Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 48: Europe 15-Year Perspective for Radiation Therapy
Equipment by Type – Percentage Breakdown of Value Sales for
External Beam Radiation Therapy, Internal Radiation Therapy and
Systemic Radiation Therapy for the Years 2012, 2021 & 2027

Table 49: Europe Recent Past, Current & Future Analysis for
Radiation Therapy Equipment by End-Use – Hospitals and Other
End-Uses – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 50: Europe Historic Review for Radiation Therapy
Equipment by End-Use – Hospitals and Other End-Uses Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 51: Europe 15-Year Perspective for Radiation Therapy
Equipment by End-Use – Percentage Breakdown of Value Sales for
Hospitals and Other End-Uses for the Years 2012, 2021 & 2027

FRANCE
Table 52: France Recent Past, Current & Future Analysis for
Radiation Therapy Equipment by Type – External Beam Radiation
Therapy, Internal Radiation Therapy and Systemic Radiation
Therapy – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 53: France Historic Review for Radiation Therapy
Equipment by Type – External Beam Radiation Therapy, Internal
Radiation Therapy and Systemic Radiation Therapy Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 54: France 15-Year Perspective for Radiation Therapy
Equipment by Type – Percentage Breakdown of Value Sales for
External Beam Radiation Therapy, Internal Radiation Therapy and
Systemic Radiation Therapy for the Years 2012, 2021 & 2027

Table 55: France Recent Past, Current & Future Analysis for
Radiation Therapy Equipment by End-Use – Hospitals and Other
End-Uses – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 56: France Historic Review for Radiation Therapy
Equipment by End-Use – Hospitals and Other End-Uses Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 57: France 15-Year Perspective for Radiation Therapy
Equipment by End-Use – Percentage Breakdown of Value Sales for
Hospitals and Other End-Uses for the Years 2012, 2021 & 2027

GERMANY
Table 58: Germany Recent Past, Current & Future Analysis for
Radiation Therapy Equipment by Type – External Beam Radiation
Therapy, Internal Radiation Therapy and Systemic Radiation
Therapy – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 59: Germany Historic Review for Radiation Therapy
Equipment by Type – External Beam Radiation Therapy, Internal
Radiation Therapy and Systemic Radiation Therapy Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 60: Germany 15-Year Perspective for Radiation Therapy
Equipment by Type – Percentage Breakdown of Value Sales for
External Beam Radiation Therapy, Internal Radiation Therapy and
Systemic Radiation Therapy for the Years 2012, 2021 & 2027

Table 61: Germany Recent Past, Current & Future Analysis for
Radiation Therapy Equipment by End-Use – Hospitals and Other
End-Uses – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 62: Germany Historic Review for Radiation Therapy
Equipment by End-Use – Hospitals and Other End-Uses Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 63: Germany 15-Year Perspective for Radiation Therapy
Equipment by End-Use – Percentage Breakdown of Value Sales for
Hospitals and Other End-Uses for the Years 2012, 2021 & 2027

ITALY
Table 64: Italy Recent Past, Current & Future Analysis for
Radiation Therapy Equipment by Type – External Beam Radiation
Therapy, Internal Radiation Therapy and Systemic Radiation
Therapy – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 65: Italy Historic Review for Radiation Therapy Equipment
by Type – External Beam Radiation Therapy, Internal Radiation
Therapy and Systemic Radiation Therapy Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 66: Italy 15-Year Perspective for Radiation Therapy
Equipment by Type – Percentage Breakdown of Value Sales for
External Beam Radiation Therapy, Internal Radiation Therapy and
Systemic Radiation Therapy for the Years 2012, 2021 & 2027

Table 67: Italy Recent Past, Current & Future Analysis for
Radiation Therapy Equipment by End-Use – Hospitals and Other
End-Uses – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 68: Italy Historic Review for Radiation Therapy Equipment
by End-Use – Hospitals and Other End-Uses Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 69: Italy 15-Year Perspective for Radiation Therapy
Equipment by End-Use – Percentage Breakdown of Value Sales for
Hospitals and Other End-Uses for the Years 2012, 2021 & 2027

UNITED KINGDOM
Market Overview
EXHIBIT 36: Number of New Cancer Cases Diagnosed (in Thousands)
in the UK: 2018
Market Analytics
Table 70: UK Recent Past, Current & Future Analysis for
Radiation Therapy Equipment by Type – External Beam Radiation
Therapy, Internal Radiation Therapy and Systemic Radiation
Therapy – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 71: UK Historic Review for Radiation Therapy Equipment by
Type – External Beam Radiation Therapy, Internal Radiation
Therapy and Systemic Radiation Therapy Markets – Independent

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05442588/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________


GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

XtalPi Unveils XtalGazer: A Comprehensive AI-Driven Polymorph Selection Platform

Published

on

xtalpi-unveils-xtalgazer:-a-comprehensive-ai-driven-polymorph-selection-platform

CAMBRIDGE, Mass., March 28, 2024 /PRNewswire/ — XtalPi Inc., a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaking medicine and innovative materials, announced today the launch of its proprietary comprehensive solid form discovery and selection platform, XtalGazer. This advanced platform aims to significantly improve the polymorph selection process for the pharmaceutical industry by integrating AI- and automation-powered experimental and computational approaches.

XtalGazer provides a total solution for delivering high-quality polymorph screening and selection methods to expedite drug development and mitigate risks. It represents a paradigm shift in solid-state research, moving from the traditional trial-and-error approach to a data-driven, design-led methodology. The platform provides an expansive suite of foundational tools to accelerate polymorph discovery, characterization, and selection process, empowering pharmaceutical companies to conduct thorough research with less active pharmaceutical ingredient (API) in shorter development cycles.
A key component of XtalGazer is XtalCSP, a crystal structure prediction platform to perform global searches of crystal structures for target molecules and the other optional components in the corresponding searching space, offering a deep insight into possible stable forms. Furthermore, crystallization strategy recommendations will provide AI-backed experimental design to help avoid human bias. XtalGazer also utilizes MicroED to rapidly elucidate crystal structures from powder samples, reducing the need for growing single crystals.
XtalPi’s launch of XtalGazer marks another significant step in the company’s ongoing exploration of solid-state research. From crystal structure prediction platforms being one of the first products to launch at XtalPi, to today’s comprehensive polymorph selection platform, XtalPi will keep fulfilling its promise to solving challenging problems in this space. XtalPi will continue to deliver faster, more accurate, and more comprehensive approaches to building an ecosystem for the R&D process in solid-state, pre-formulation and crystallization.
For more information about XtalPi, please visit www.xtalpi.com.
About XtalPi:
XtalPi is an innovative technology company powered by artificial intelligence (AI) and robotics. Founded in 2015 on the MIT campus, XtalPi is dedicated to driving intelligent and digital transformation in the life science and new materials industries. With tightly interwoven quantum physics, AI, cloud computing, and large-scale clusters of robotic workstations, XtalPi offers a range of technology solutions, services, and products to accelerate and empower innovation for biopharmaceutical and new materials companies worldwide.
Media Contact: Vivienne [email protected]
Logo – https://mma.prnewswire.com/media/632519/XtalPi_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/xtalpi-unveils-xtalgazer-a-comprehensive-ai-driven-polymorph-selection-platform-302102794.html

Continue Reading

Artificial Intelligence

ICIS and Base Oil News Announce Partnership to Enhance Market Insights

Published

on

icis-and-base-oil-news-announce-partnership-to-enhance-market-insights

LONDON, March 28, 2024 /PRNewswire/ — ICIS, a global source of commodity intelligence, is pleased to announce a strategic partnership with Base Oil News, a premier news outlet founded by industry expert Iain Pocock that provides in-depth coverage of the base oils and lubricants market. This collaboration marks a significant milestone in the dissemination and exchange of critical market data and insights.

With more than two decades of journalism experience at Bloomberg, Reuters, and Argus Media, Iain Pocock brings unparalleled expertise to this partnership. His deep understanding of illiquid energy markets makes him a credible and influential figure in the industry. Since November 2023, Iain has been working closely with ICIS to share and exchange valuable data and insights, enhancing the services both platforms offer to the base oils and lubricants market.
Through the collaboration, Iain integrates ICIS’ extensive content and data resources in Base Oil News market coverage. In return, he contributes market insights to ICIS News, including expert and exclusive analysis of supply and demand dynamics, price margins, and other critical market drivers. This exchange ensures that subscribers of both ICIS and Base Oil News have access to the most comprehensive, timely, and accurate market information, empowering them to make informed decisions.
“It’s a very exciting partnership – where we leverage each other’s strengths and provide actionable insights to our customers,” said Iain Pocock, Founder of Base Oil News. “The market is the winner.”
“As ICIS is already the world’s most trusted pricing benchmark for base oils, this collaboration with Iain Pocock and Base Oil News provides an even stronger and deeper service to our customers,” said Stephen Burns, Editorial Director at ICIS. “Iain’s expertise and extensive industry connections are invaluable, and we have established a fruitful partnership that benefits the market at large.”
For the latest insights from Iain Pocock on ICIS News, visit ICIS News.  
About ICIS
ICIS – Independent Commodity Intelligence Services – helps businesses through seamlessly delivering data and analytics, across the chemical, fertilizer and energy markets. A trusted source and benchmark for price information and insight across key commodities markets worldwide. Our independent, transparent market intelligence informs thousands of quality decisions every day, taking the pressure out of negotiations and giving customers space for more innovative thinking, through published datasets including price assessments, price forecasts, supply and demand fundamentals and more.
Over 150 years of shaping the world by connecting markets to optimise the world’s valuable resources. With a global team of more than 600 experts, ICIS has employees based in London, New York, Houston, Karlsruhe, Milan, Mumbai, Singapore, Guangzhou, Beijing, Shanghai, Dubai, Sao Paulo, Seoul, Tokyo and Perth.
ICIS is part of RELX, a FTSE15 company with a market cap of £64bn and an employee base of over 30,000 experts across 40 countries.
About RELX
RELX is a global provider of information and analytics for professional and business customers across industries. The Group serves customers in more than 180 countries and has offices in about 40 countries. It employs approximately 30,000 people of whom almost half are in North America. RELX PLC is a London listed holding company which owns 52.9% of RELX Group. RELX NV is an Amsterdam listed holding company which owns 47.1% of RELX Group. The shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX and RENX. Total market capitalisation is approximately £64bn | €75bn | $81bn.
Logo: https://mma.prnewswire.com/media/619935/4277787/ICIS_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/icis-and-base-oil-news-announce-partnership-to-enhance-market-insights-302102782.html

Continue Reading

Artificial Intelligence

Trianz Welcomes Israel Abraham as Vice President of Services for Extrica.ai – The Data to AI Platform

Published

on

trianz-welcomes-israel-abraham-as-vice-president-of-services-for-extrica.ai-–-the-data-to-ai-platform

SANTA CLARA, Calif., March 28, 2024 /PRNewswire/ — Digital transformation technology & services company Trianz is pleased to announce the appointment of Israel Abraham as Vice President of Extrica Platform Services.

Trianz has embarked on a transformative journey, redefining its value proposition with an ‘IP Led’ model, with a commitment to deliver the fastest time to value, lowest human dependence, and highest ROI. Central to this approach are our hyper-automated platforms, Concierto.Cloud, Extrica.AI, and Pulse, driving industry-leading transformations in cloud, data and analytics, AI, and the digital workplace.
Israel Abraham is a very well-known pioneer and industry leader in AI, data management, and analytics systems, with over three decades of experience. He joins as the services leader for Extrica- the Trianz Data to AI platform, which productizes data, provides data a face and purpose, and accelerates time to insights and AI by 50% or more. In the role of Extrica Services leader, Israel will lead the shaping, visioning, and delivery of Extrica.ai based enterprise wide datamesh, BI, and AI solutions for customers worldwide.
“We are thrilled to welcome Israel Abraham to the Trianz family,” said Sri Manchala, CEO of Trianz and author of Crossing the Digital Faultline. “He is a leader in modernization as well as conceptualization of data platforms anew. Israel’s prior background in the industry with financial services and insurance giants underscores our commitment to securing top-tier talent that brings real-world experiences and needs to our technology platforms. As we continue to broaden our footprint in the digital transformation space, Israel’s visionary leadership and practical experience will serve as the cornerstone in accelerating insights and AI to deliver transformative value to our clients.”
Having played pivotal roles in highly reputed and large organizations such as Liberty Mutual Insurance, MassMutual, Safeco, and CNA Insurance, Israel has garnered recognition as a seasoned leader in big data and AI cloud implementations. His accolades include the prestigious 2014 Ventana Research IT Innovation Award, the 2009 Informatica MDM Innovation Award, and three filed Data Engineering patents in the last four years.
“Trianz has been at the forefront of digital innovation, and Extrica.ai is a paradigm shifting data to AI platform that completely changes how analytics and AI are delivered- much faster, taking business ahead of change. I am excited to scale the adoption of the Extrica platform, which has attracted attention from giants across the industry and hyperscalers,” said Israel Abraham. “I look forward to engaging with customers, bringing my own experiences, and collaborating with the talented team at Trianz to further enhance the capabilities of the Extrica Platform Services to transform data & AI strategies, execution, and outcomes for customers.”
About Trianz
Trianz is a leading-edge technology platforms and services company that accelerates digital transformations at Fortune 100 and emerging companies worldwide in data & analytics, digital experiences, cloud infrastructure, and security. Our ‘IP Led Transformations’ approach, informed by insights from a recent global study spanning 20+ industries and 5000+ companies, addresses challenges posed by the rapid pace of AI-driven transformation, digital talent scarcity, and economic uncertainty. Our IP and platforms, including Concierto, Extrica, and Pulse, revolutionize cloud adoption, data analytics, and AI insights, empowering organizations to navigate the complexities of digital transformation seamlessly.
Founded in California and with an organization of over 2,000 associates across the United States and India, Trianz is a Premier Partner of AWS, consistently rated #1 by clients for value delivery over the past five years. Trianz has been ranked as one of the best Consulting Firms by Forbes and has been certified as a Great Place to Work for three years in a row. To learn more about Trianz, email [email protected] or visit www.trianz.com.
Watch Trianz CEO Sri Manchala’s insightful interview with Bloomberg on Partner | Crossing The Digital Faultline & Leading Towards Transformative Success – YouTube and delve deeper into his book Crossing the Digital Faultline at Crossing the Digital Faultline | Trianz.
Trianz Media [email protected] +1-408-387-5800
Logo: https://mma.prnewswire.com/media/626944/1199800/Trianz_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/trianz-welcomes-israel-abraham-as-vice-president-of-services-for-extricaai–the-data-to-ai-platform-302102589.html

Continue Reading
Advertisement

Latest News

Trending